M&T Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.93M | Sell |
6,376
-59
| -0.9% | -$45.2K | 0.02% | 392 |
|
|
2025
Q4 | $4.97M | Buy |
6,435
+1,096
| +21% | +$744K | 0.02% | 411 |
|
|
2025
Q3 | $3M | Sell |
5,339
-590
| -10% | -$334K | 0.01% | 485 |
|
|
2025
Q2 | $3.11M | Buy |
5,929
+843
| +17% | +$471K | 0.01% | 505 |
|
|
2025
Q1 | $3.23M | Sell |
5,086
-282
| -5% | -$194K | 0.01% | 480 |
|
|
2024
Q4 | $3.82M | Sell |
5,368
-112
| -2% | -$94K | 0.01% | 492 |
|
|
2024
Q3 | $5.76M | Buy |
5,480
+224
| +4% | +$249K | 0.02% | 407 |
|
|
2024
Q2 | $5.52M | Sell |
5,256
-314
| -6% | -$304K | 0.02% | 406 |
|
|
2024
Q1 | $5.36M | Buy |
5,570
+241
| +5% | +$229K | 0.02% | 418 |
|
|
2023
Q4 | $4.68M | Sell |
5,329
-94
| -2% | -$77.4K | 0.02% | 424 |
|
|
2023
Q3 | $4.46M | Buy |
5,423
+25
| +0.5% | +$19.6K | 0.02% | 423 |
|
|
2023
Q2 | $3.88M | Buy |
5,398
+2
| +0% | +$1.54K | 0.01% | 463 |
|
|
2023
Q1 | $4.43M | Buy |
5,396
+899
| +20% | +$678K | 0.02% | 441 |
|
|
2022
Q4 | $3.24M | Sell |
4,497
-695
| -13% | -$513K | 0.01% | 496 |
|
|
2022
Q3 | $3.58M | Sell |
5,192
-728
| -12% | -$458K | 0.02% | 448 |
|
|
2022
Q2 | $2.87M | Buy |
5,920
+1,662
| +39% | +$1.08M | 0.01% | 472 |
|
|
2022
Q1 | $2.98M | Buy |
4,258
+25
| +0.6% | +$15.8K | 0.01% | 461 |
|
|
2021
Q4 | $2.67M | Buy |
4,233
+19
| +0.5% | +$11.7K | 0.01% | 502 |
|
|
2021
Q3 | $2.55M | Buy |
4,214
+152
| +4% | +$94.4K | 0.01% | 505 |
|
|
2021
Q2 | $2.27M | Sell |
4,062
-34
| -0.8% | -$17.2K | 0.01% | 533 |
|
|
2021
Q1 | $1.94M | Sell |
4,096
-1,489
| -27% | -$725K | 0.01% | 564 |
|
|
2020
Q4 | $2.7M | Sell |
5,585
-631
| -10% | -$341K | 0.01% | 496 |
|
|
2020
Q3 | $3.48M | Sell |
6,216
-1,036
| -14% | -$628K | 0.02% | 411 |
|
|
2020
Q2 | $4.52M | Sell |
7,252
-848
| -10% | -$481K | 0.02% | 349 |
|
|
2020
Q1 | $3.95M | Sell |
8,100
-906
| -10% | -$374K | 0.02% | 373 |
|
|
2019
Q4 | $3.38M | Buy |
9,006
+545
| +6% | +$183K | 0.02% | 340 |
|
|
2019
Q3 | $2.35M | Buy |
8,461
+3,609
| +74% | +$1.07M | 0.01% | 481 |
|
|
2019
Q2 | $1.52M | Sell |
4,852
-1,549
| -24% | -$516K | 0.01% | 602 |
|
|
2019
Q1 | $2.63M | Sell |
6,401
-15
| -0.2% | -$6.18K | 0.01% | 457 |
|
|
2018
Q4 | $2.4M | Sell |
6,416
-1,373
| -18% | -$503K | 0.01% | 447 |
|
|
2018
Q3 | $3.15M | Buy |
7,789
+346
| +5% | +$132K | 0.02% | 438 |
|
|
2018
Q2 | $2.57M | Sell |
7,443
-670
| -8% | -$210K | 0.01% | 486 |
|
|
2018
Q1 | $2.79M | Sell |
8,113
-7,114
| -47% | -$2.47M | 0.02% | 466 |
|
|
2017
Q4 | $5.72M | Sell |
15,227
-2,341
| -13% | -$948K | 0.03% | 328 |
|
|
2017
Q3 | $7.86M | Sell |
17,568
-1,908
| -10% | -$908K | 0.04% | 281 |
|
|
2017
Q2 | $9.57M | Sell |
19,476
-3,843
| -16% | -$1.68M | 0.06% | 243 |
|
|
2017
Q1 | $9.04M | Sell |
23,319
-26,628
| -53% | -$9.87M | 0.05% | 242 |
|
|
2016
Q4 | $18.3M | Sell |
49,947
-2,072
| -4% | -$788K | 0.11% | 176 |
|
|
2016
Q3 | $20.9M | Sell |
52,019
-4,846
| -9% | -$1.94M | 0.13% | 153 |
|
|
2016
Q2 | $19.9M | Buy |
56,865
+4,818
| +9% | +$1.86M | 0.13% | 164 |
|
|
2016
Q1 | $18.8M | Buy |
52,047
+1,281
| +3% | +$528K | 0.13% | 165 |
|
|
2015
Q4 | $27.6M | Buy |
50,766
+3,274
| +7% | +$1.77M | 0.18% | 122 |
|
|
2015
Q3 | $22.1M | Sell |
47,492
-3,189
| -6% | -$1.71M | 0.15% | 140 |
|
|
2015
Q2 | $25.9M | Sell |
50,681
-10,470
| -17% | -$5.11M | 0.16% | 129 |
|
|
2015
Q1 | $27.6M | Buy |
61,151
+1,483
| +2% | +$628K | 0.17% | 124 |
|
|
2014
Q4 | $24.5M | Sell |
59,668
-3,454
| -5% | -$1.36M | 0.15% | 132 |
|
|
2014
Q3 | $22.8M | Buy |
63,122
+49,133
| +351% | +$16.5M | 0.15% | 127 |
|
|
2014
Q2 | $3.95M | Buy |
13,989
+9,989
| +250% | +$2.96M | 0.17% | 115 |
|
|
2014
Q1 | $1.2M | Sell |
4,000
-49
| -1% | -$15.1K | 0.05% | 233 |
|
|
2013
Q4 | $1.11M | Sell |
4,049
-1,107
| -21% | -$318K | 0.05% | 251 |
|
|
2013
Q3 | $1.61M | Sell |
5,156
-1,220
| -19% | -$321K | 0.08% | 174 |
|
|
2013
Q2 | $1.43M | Buy |
+6,376
| New | +$1.48M | 0.07% | 198 |
|
Other funds holding REGN
VCM
N
M&T Bank's REGN Position: Q1 2026 in Review
M&T Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 0.92% in Q1 2026, selling an estimated $45.2K and leaving 6,376 shares worth $4.93M. The position accounts for 0.02% of the portfolio, ranked #392.
M&T Bank first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.6M in Q1 2015. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- M&T Bank held 6,376 shares of Regeneron Pharmaceuticals worth $4.93M as of Q1 2026.
- M&T Bank sold 59 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $45.2K.
- Regeneron Pharmaceuticals made up 0.02% of M&T Bank's portfolio in Q1 2026, its #392 holding.
- M&T Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- M&T Bank's Regeneron Pharmaceuticals position peaked at $27.6M in Q1 2015.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.